3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 33558279 | Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with ROS1-rearranged lung adenocarcinoma. | 2021 Feb | 1 |
| 2 | 32208297 | A novel ROS1 G2032 K missense mutation mediates lorlatinib resistance in a patient with ROS1-rearranged lung adenocarcinoma but responds to nab-paclitaxel plus pembrolizumab. | 2020 May | 1 |
| 3 | 32914039 | Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation. | 2019 | 1 |